Will you be our new Communications Associate?
Communications Associate for a foundation in Belgium If you [...]
February 2023 – The Third Edition of Radiotheranostics Today is out!
February 4th is World Cancer Day! Access for all in [...]
Thank you for your support!
Your support and contributions at the heart of the fight [...]
Doctor, will radiotheranostics make me radioactive?
You’ve been asking for it, and we did it! The [...]
EANM response to ASTRO’s framework for trainees
Letter to Editor for “European Association of Nuclear Medicine (EANM) [...]
A major component to successfully establish radioligand therapy
Tackling the Last Mile: A major component to successfully establish [...]
Happy New Year !
From all of us at the Oncidium foundation to you [...]
European Commission approves Pluvicto™
European Commission Approves Pluvicto for PSMA-Positive mCRPC OncLive, Dec 14, [...]
Novel PET Agent to Identify Patients for Targeted Therapies
Novel PET Agent Effectively Detects Multiple Cancers, Identifies Patients for [...]
Quo Vadis, Teragnosis?
Vercher-Conejero JL. Quo Vadis, Teragnosis? Rev Esp Med Nucl Imagen [...]